Advertisement

Topics

BioTissue Technologies GmbH Company Profile

13:54 EST 24th November 2017 | BioPortfolio

BioTissue Technologies is a pioneer in the biotechnology field of tissue engineering. For over seven years we have been developing and producing "autologous tissue replacements" to restore missing or damaged bone or cartilage tissue.

Location

Engesserstraße 4b
Freiburg
D-79108
Germany

Contact

Phone: 49 (0)761 76 76-100
Fax: 49 (0)761 76 76-150
Email: info@biotissue-tec.com


News Articles [374 Associated News Articles listed on BioPortfolio]

Advanced Enzymes acquires evoxx

The industrial biotechnology company evoxx technologies GmbH has become a part of specialty biotech company Advanced Enzyme Technologies Limited. Both companies announced that they have entered into a...

EBS Technologies GmbH Appoints As Chief Executive Officer

  Life Sciences Jobs   ...

Royalties under patent licence agreements: can they remain payable even if the licensed patents(s) are revoked or not practised? Lessons from Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH

Précis In its recent decision in Genentech Inc v Hoechst GmbH & Sanofi-Aventis Deutschland GmbH (7 July 2016), the Court of Justice of the EU (“CJEU”) has ruled that an obligati...

BioStorage® Technologies GMBH, la filiale de Brooks Life Science Systems dans l'Union ...

Le CIR permet aux entreprises fondées sur la recherche y ayant droit, qui sont soumises à l'impôt sur les sociétés en France, de demander Read more...

BioStorage® Technologies GMBH recibe el crédito fiscal a la investigación (CIR)

El CIR permite a las empresas de investigación aptas, y sujetas a pagar el impuesto de sociedades en Francia, la oportunidad de solicitar una deducción Read more...

BioStorage® Technologies GMBH, das EU-Tochterunternehmen von Brooks Life Science Systems, ...

Der CIR-Status ermöglicht es Forschungsunternehmen, die in Frankreich der Körperschaftssteuer unterliegen, eine Steuerreduktion von 30 Prozent zu beantragen, basierend auf allen F&E-Ausgaben, ...

Endocyte licenses radioligand prostate cancer therapy from ABX GMBH

Endocyte Inc. received exclusive global rights to the radioligand therapeutic PSMA617 (177LuPSMA617) from ABX GMBH.

DGAP-News: GBC Kapital GmbH: Erfolgreich abgeschlossene Kapitalmaßnahme der SYGNIS AG - beide Kapitalerhöhungen wurden von der GBC Kapital GmbH und der MC Services AG, jeweils als Co-Lead Manager Institutional Sales, begleitet und waren signifikant

GBC Kapital GmbH: Erfolgreich abgeschlossene Kapitalmaßnahme der SYGNIS AG - beide Kapitalerhöhungen wurden von der GBC Kapital GmbH und der MC Services AG, jeweils als Co-Lead Manager Institution.....

PubMed Articles [353 Associated PubMed Articles listed on BioPortfolio]

Direct numerical simulation of the initial stage of a thermally induced microcavitation in a water-rich biotissue triggered by a nanosecond pulsed laser.

Health technology assessments conducted in health care facilities: A strategic practice? Findings from a content analysis of HTA reports.

In this paper, we test the hypothesis that health technology assessment units located in hospitals tend to be more optimistic toward technologies that are currently in use in their organization than t...

Enhancing the Gaming Experience Using 3D Spatial User Interface Technologies.

Three-dimensional (3D) spatial user interface technologies have the potential to make games more immersive and engaging and thus provide a better user experience. Although technologies such as stereos...

A brief review of single-cell transcriptomic technologies.

In recent years, there has been an effort to develop new technologies for measuring gene expression and sequence information from thousands of individual cells. Large data sets that were obtained usin...

Technologies to Support Community-Dwelling Persons With Dementia: A Position Paper on Issues Regarding Development, Usability, Effectiveness and Cost-Effectiveness, Deployment, and Ethics.

With the expected increase in the numbers of persons with dementia, providing timely, adequate, and affordable care and support is challenging. Assistive and health technologies may be a valuable cont...

Clinical Trials [368 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Companies [1751 Associated Companies listed on BioPortfolio]

BioTissue Technologies GmbH

BioTissue Technologies is a pioneer in the biotechnology field of tissue engineering. For over seven years we have been developing and producing "autologous tissue replacements" to restore missing or ...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

Ormecon GmbH

Ormecon GmbH, with its location in Ammersbek/Germany, is the headquarter of Ormecon International. Ormecon GmbH was originally founded as "Ormecon Chemie GmbH & Co. KG" in 1996, as a 100% subsidiary o...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

GYMWATCH GmbH

GYMWATCH GmbH develops advanced fitness technologies and devices. Based in Darmstadt, Germany, near Frankfurt, the company’s first product is the patented GYMWATCH Sensor, wh...

More Information about "BioTissue Technologies GmbH" on BioPortfolio

We have published hundreds of BioTissue Technologies GmbH news stories on BioPortfolio along with dozens of BioTissue Technologies GmbH Clinical Trials and PubMed Articles about BioTissue Technologies GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioTissue Technologies GmbH Companies in our database. You can also find out about relevant BioTissue Technologies GmbH Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...


Corporate Database Quicklinks



Searches Linking to this Company Record